ORTHOPEDIATRICS CORP·4

Jun 10, 9:49 AM ET

Infante (Reynolds) Marie C 4

4 · ORTHOPEDIATRICS CORP · Filed Jun 10, 2026

Research Summary

AI-generated summary of this filing

Updated

Orthopediatrics (KIDS) Director Marie C. Infante Receives Award

What Happened
Marie C. Infante, a director of Orthopediatrics Corp (KIDS), was reported on a Form 4 to have acquired 11,436 shares on 2026-06-09 via a grant/award (transaction code A). The reported acquisition price is $0.00, indicating these shares were issued as a restricted stock award (company compensation), with no cash exchanged in the transaction.

Key Details

  • Transaction date: 2026-06-09; Form 4 filed: 2026-06-10 (timely filing).
  • Reported price: $0.00 (award/grant). Reported value shown as $0 for the transfer.
  • Footnote: Filing notes “Includes restricted stock awards totaling 17,959 shares” (may reflect total restricted shares held or included in the reporting schedule).
  • Shares owned after transaction: Not specified in the available filing details.
  • Filing timeliness: The Form 4 was filed within the standard reporting window (not late).

Context
Restricted stock awards are typically compensation for directors and vest over time; they are not open-market purchases and do not represent an immediate cash investment by the insider. Such grants are common and should be viewed as part of compensation rather than a direct buy/sell signal.

Insider Transaction Report

Form 4
Period: 2026-06-09
Transactions
  • Award

    Common Stock

    [F1]
    2026-06-09+11,43631,202 total
Footnotes (1)
  • [F1]Includes restricted stock awards totaling 17,959 shares.
Signature
/s/ Daniel J. Gerritzen, Attorney-in-Fact|2026-06-10

Documents

1 file
  • 4
    wk-form4_1781099352.xmlPrimary

    FORM 4